Skip to content

Author

David Y. Zhang

We have 4 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study.

RATIONALE & OBJECTIVE Angiopoietin-like proteins (ANGPTL) 3 and 4 modulate lipoprotein metabolism through inhibition of lipases. Reduced activity of ANGPTL3 and ANGPTL4 improves kidney function in mice. This study aimed to investigate the causal relationships of ANGPTLs and their lipase targets with chronic kidney dise...

Guo-Yi Yang, David Y. Zhang, Clara J. Fischman et al. · 0 citations
Open access Sep 2026

ARCHER-LD: Rapid Long-Range Linkage Disequilibrium Calculations at Biobank Scale using GPU Acceleration

Linkage disequilibrium (LD) information from one’s own dataset is considered optimal for downstream analyses such as statistical fine-mapping. However, the computational complexity ( computations for N variants) lead most studies to use external reference panels, such as from 1000 Genomes. To capture LD across all vari...

Rachit Kumar, Pankhuri Singhal, David Y. Zhang et al. · 0 citations
Open access Aug 2026

Machine learning for population-level risk prediction of future cholangiocarcinoma

It is shown that ML models integrating biliary-disease associated health records and Gamma glutamyltransferase can stratify risk of future CCA, and demonstrates the potential of data-driven models in personalised screening for hepatobiliary cancer.

F. van Haag, J. Clusmann, Paul-Henry Koop et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.